Clinic
Dignity Health Medical Foundation
Dignity Health Medical Foundation was paid $6.11M by Medicaid between Jan 2018 and Nov 2024, across 308 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 15% of everything it billed.
33Billing provider infoDIGNITY HEALTH MEDICAL FOUNDATION
WOODLAND, CA 95695
WOODLAND, CA 95695
33aNPI1144497678assigned 05/14/2008
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$6.11M
24GClaims547,624
24DCodes billed308
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in California
Rank by total paid#19 of 170
Median peer was paid$145K
This provider vs. median42×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HYLEN, THERESA controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,610 | $304K | |
| 2019 | 13,075 | $347K | |
| 2020 | 60,327 | $699K | |
| 2021 | 109,083 | $795K | |
| 2022 | 135,924 | $1.01M | |
| 2023 | 144,237 | $1.46M | |
| 2024incomplete | 71,368 | $1.49M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 90,470 | 86,847 | $905K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.4% | 91,014 | 86,461 | $575K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.5% | 9,669 | 8,404 | $456K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 6.2% | 11,331 | 10,916 | $376K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5.8% | 4,432 | 4,344 | $357K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.5% | 10,594 | 10,400 | $278K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2.5% | 15,256 | 13,184 | $156K |
| G9012 | Other specified case management service not elsewhere classified | 2.5% | 870 | 528 | $154K |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 2.4% | 700 | 515 | $148K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 2.3% | 1,543 | 842 | $138K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.1% | 3,286 | 3,230 | $127K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.9% | 1,023 | 562 | $115K |
296 more codes
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 1.9% | 5,159 | $114K |
| 20611 | 1.9% | 3,556 | $113K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 2,877 | $107K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.7% | 4,490 | $105K |
| 95144 | 1.6% | 9,707 | $96K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 1.5% | 385 | $93K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.2% | 626 | $76K |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 1.2% | 2,603 | $75K |
| 99205 | Prolong outpt/office vis | 1.2% | 1,249 | $70K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.0% | 538 | $62K |
| 92551 | <1% | 5,165 | $59K | |
| 0012A | <1% | 1,423 | $56K | |
| S9083 | Global fee urgent care centers | <1% | 722 | $54K |
| 0011A | <1% | 1,434 | $53K | |
| 93000 | <1% | 4,888 | $51K | |
| 92557 | <1% | 999 | $50K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 1,302 | $46K |
| H0031 | Mental health assessment, by non-physician | <1% | 75 | $41K |
| 94060 | <1% | 1,464 | $40K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 432 | $35K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,612 | $35K |
| 99223 | Prolong inpt eval add15 m | <1% | 782 | $35K |
| 92567 | <1% | 867 | $34K | |
| 94726 | <1% | 1,137 | $33K | |
| 94729 | <1% | 1,128 | $33K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 2,418 | $32K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 917 | $32K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,083 | $30K |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | <1% | 252 | $28K |
| 87428 | <1% | 425 | $27K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,444 | $25K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 478 | $23K |
| 51798 | <1% | 797 | $22K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,532 | $20K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 332 | $20K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 420 | $20K |
| 20550 | <1% | 940 | $19K | |
| 95117 | <1% | 6,316 | $19K | |
| 64615 | <1% | 362 | $17K | |
| 93224 | <1% | 295 | $16K | |
| 90686 | <1% | 8,686 | $16K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,216 | $16K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 57 | $16K |
| V5298 | Hearing aid, not otherwise classified | <1% | 12 | $16K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,306 | $16K |
| 76942 | <1% | 1,137 | $15K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 801 | $15K |
| 99243 | <1% | 229 | $14K | |
| 90670 | <1% | 1,892 | $13K | |
| 99221 | <1% | 437 | $11K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 624 | $11K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,694 | $10K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,156 | $10K |
| 90648 | <1% | 2,296 | $10K | |
| 95885 | <1% | 300 | $10K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 3,680 | $10K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 28 | $9K |
| 90651 | <1% | 1,084 | $9K | |
| 59025 | Fetal non-stress test | <1% | 1,849 | $7K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,150 | $7K |
| 90723 | <1% | 1,096 | $7K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,187 | $7K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 132 | $6K |
| 92134 | <1% | 403 | $6K | |
| Z1034 | <1% | 102 | $5K | |
| 95012 | <1% | 554 | $5K | |
| 76519 | <1% | 628 | $5K | |
| 90677 | <1% | 396 | $5K | |
| 0072A | <1% | 129 | $5K | |
| 17110 | <1% | 94 | $5K | |
| 0064A | <1% | 129 | $5K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 15 | $4K |
| 95806 | <1% | 62 | $4K | |
| 92136 | <1% | 227 | $4K | |
| 95115 | <1% | 1,993 | $4K | |
| 0071A | <1% | 109 | $4K | |
| 99245 | <1% | 27 | $3K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 19 | $3K |
| 93015 | <1% | 78 | $3K | |
| 92133 | <1% | 356 | $3K | |
| 0124A | <1% | 84 | $3K | |
| 90656 | <1% | 955 | $3K | |
| 99152 | <1% | 61 | $3K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 499 | $3K |
| 99310 | Prolong nursin fac eval 15m | <1% | 442 | $3K |
| 90680 | <1% | 348 | $3K | |
| 0031A | <1% | 62 | $2K | |
| 0001A | <1% | 73 | $2K | |
| 0134A | <1% | 61 | $2K | |
| 92002 | <1% | 194 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,258 | $2K |
| 93016 | <1% | 154 | $2K | |
| 0002A | <1% | 53 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 253 | $2K |
| H1002 | Prenatal care, at risk enhanced service; care coordination | <1% | 41 | $2K |
| 90681 | <1% | 215 | $2K | |
| 93018 | <1% | 182 | $2K | |
| 92083 | <1% | 126 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 192 | $2K |
| 99499 | <1% | 422 | $2K | |
| 92588 | <1% | 26 | $1K | |
| 59425 | <1% | 20 | $1K | |
| 99242 | <1% | 173 | $1K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 19 | $1K |
| 90734 | <1% | 459 | $1K | |
| 99307 | <1% | 253 | $1K | |
| 0154A | <1% | 30 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 112 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,440 | $982.16 |
| 81003 | <1% | 1,231 | $921.52 | |
| 20610 | <1% | 32 | $888.63 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,537 | $825.26 |
| 76830 | Ultrasound, transvaginal | <1% | 77 | $794.88 |
| 11721 | <1% | 43 | $745.00 | |
| 90694 | <1% | 353 | $702.75 | |
| 81025 | <1% | 292 | $697.66 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 31 | $669.10 |
| 96160 | <1% | 84 | $653.26 | |
| 95910 | <1% | 12 | $634.39 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 351 | $631.92 |
| 95886 | <1% | 12 | $631.65 | |
| 90633 | <1% | 377 | $631.02 | |
| 81002 | <1% | 1,164 | $574.98 | |
| 85018 | <1% | 3,348 | $532.44 | |
| 20551 | <1% | 69 | $524.16 | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 41 | $516.58 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,712 | $514.34 |
| 0112A | <1% | 15 | $510.00 | |
| 96127 | <1% | 967 | $495.83 | |
| 94010 | <1% | 24 | $482.60 | |
| 99201 | <1% | 34 | $471.80 | |
| 0054A | <1% | 12 | $460.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 45 | $448.56 |
| 99384 | <1% | 15 | $444.36 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,409 | $441.98 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 53 | $429.10 |
| 99070 | <1% | 16 | $416.25 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 28 | $394.41 |
| 11750 | <1% | 16 | $390.85 | |
| 69210 | <1% | 16 | $379.14 | |
| 99188 | <1% | 153 | $374.45 | |
| 90710 | <1% | 102 | $341.48 | |
| G0317 | Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418). (do not report g0317 for any time unit less than 15 minutes) | <1% | 17 | $334.22 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 6,230 | $308.60 |
| 90715 | <1% | 284 | $267.47 | |
| 90620 | <1% | 51 | $263.46 | |
| 92504 | <1% | 32 | $248.06 | |
| 99406 | <1% | 13 | $211.67 | |
| 83655 | <1% | 224 | $205.20 | |
| 92700 | <1% | 38 | $198.17 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,678 | $173.42 |
| 90674 | <1% | 57 | $153.00 | |
| 90696 | <1% | 85 | $112.18 | |
| 90647 | <1% | 14 | $90.00 | |
| 93793 | <1% | 584 | $88.77 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 18 | $73.46 |
| 87807 | <1% | 116 | $66.78 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,252 | $59.14 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,788 | $35.68 |
| 87799 | <1% | 273 | $34.27 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,109 | $28.20 |
| 87481 | <1% | 911 | $28.07 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 782 | $24.73 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,536 | $23.68 |
| 81001 | <1% | 4,416 | $19.39 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,312 | $19.26 |
| 83001 | <1% | 199 | $16.41 | |
| 92499 | <1% | 12 | $14.52 | |
| 82607 | <1% | 1,099 | $13.33 | |
| 90653 | <1% | 234 | $12.54 | |
| 82728 | <1% | 2,330 | $12.07 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 176 | $11.78 |
| 86376 | <1% | 40 | $11.64 | |
| 80061 | Lipid panel | <1% | 10,656 | $11.54 |
| 80053 | Comprehensive metabolic panel | <1% | 12,610 | $9.28 |
| 84439 | <1% | 2,796 | $7.91 | |
| 85027 | <1% | 3,604 | $5.71 | |
| 87081 | <1% | 2,696 | $5.30 | |
| 82043 | <1% | 2,548 | $5.08 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $5.05 |
| 82570 | <1% | 3,116 | $4.60 | |
| 87205 | <1% | 30 | $3.46 | |
| 86592 | <1% | 3,022 | $3.41 | |
| G0008 | Administration of influenza virus vaccine | <1% | 357 | $1.60 |
| 83540 | 0% | 2,817 | $0.00 | |
| 81513 | 0% | 598 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 2,285 | $0.00 |
| 86900 | 0% | 625 | $0.00 | |
| 86708 | 0% | 92 | $0.00 | |
| 86480 | 0% | 1,006 | $0.00 | |
| 85610 | 0% | 1,573 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 2,009 | $0.00 |
| 87186 | 0% | 1,429 | $0.00 | |
| 84403 | 0% | 725 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 4,251 | $0.00 |
| 83013 | 0% | 469 | $0.00 | |
| 87660 | 0% | 382 | $0.00 | |
| 83970 | 0% | 66 | $0.00 | |
| 84146 | 0% | 54 | $0.00 | |
| 84550 | 0% | 367 | $0.00 | |
| 86787 | 0% | 510 | $0.00 | |
| 97803 | 0% | 30 | $0.00 | |
| 74018 | 0% | 39 | $0.00 | |
| 82652 | 0% | 340 | $0.00 | |
| 73630 | 0% | 206 | $0.00 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 88 | $0.00 |
| 87209 | 0% | 12 | $0.00 | |
| 87512 | 0% | 245 | $0.00 | |
| 73030 | 0% | 86 | $0.00 | |
| 84156 | 0% | 427 | $0.00 | |
| 85045 | 0% | 12 | $0.00 | |
| 76642 | 0% | 145 | $0.00 | |
| 86038 | 0% | 522 | $0.00 | |
| 80076 | 0% | 252 | $0.00 | |
| 87338 | 0% | 16 | $0.00 | |
| 84702 | 0% | 151 | $0.00 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 95 | $0.00 |
| 73610 | 0% | 67 | $0.00 | |
| 83516 | 0% | 193 | $0.00 | |
| 80074 | 0% | 105 | $0.00 | |
| 90785 | 0% | 15 | $0.00 | |
| 73110 | 0% | 31 | $0.00 | |
| 73140 | 0% | 38 | $0.00 | |
| 87045 | 0% | 12 | $0.00 | |
| 84100 | 0% | 15 | $0.00 | |
| 99199 | Unlisted special service, procedure or report | 0% | 26 | $0.00 |
| 87427 | 0% | 25 | $0.00 | |
| 72100 | 0% | 14 | $0.00 | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 40 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 134 | $0.00 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 12 | $0.00 |
| 90750 | 0% | 14 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 74 | $0.00 |
| 82627 | 0% | 12 | $0.00 | |
| 85007 | 0% | 13 | $0.00 | |
| 99401 | 0% | 13 | $0.00 | |
| 84481 | 0% | 15 | $0.00 | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 0% | 13 | $0.00 |
| 99284 | Emergency room visit (serious) | 0% | 16 | $0.00 |
| 87075 | 0% | 13 | $0.00 | |
| 87177 | 0% | 12 | $0.00 | |
| 77080 | 0% | 14 | $0.00 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 0% | 12 | $0.00 |
| 85652 | 0% | 1,903 | $0.00 | |
| 86901 | 0% | 624 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 1,109 | $0.00 |
| 82746 | 0% | 1,649 | $0.00 | |
| 87077 | 0% | 1,250 | $0.00 | |
| 86762 | 0% | 528 | $0.00 | |
| 87340 | 0% | 1,280 | $0.00 | |
| 83550 | 0% | 2,707 | $0.00 | |
| 80069 | 0% | 224 | $0.00 | |
| 83735 | 0% | 83 | $0.00 | |
| 85730 | 0% | 219 | $0.00 | |
| 86140 | 0% | 1,677 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 9,070 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 799 | $0.00 |
| 88307 | 0% | 29 | $0.00 | |
| 86850 | 0% | 579 | $0.00 | |
| 84402 | 0% | 312 | $0.00 | |
| 87480 | 0% | 382 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 1,948 | $0.00 |
| 87070 | 0% | 705 | $0.00 | |
| 86803 | 0% | 2,121 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 5,238 | $0.00 |
| 86225 | 0% | 78 | $0.00 | |
| 82951 | 0% | 414 | $0.00 | |
| 88142 | 0% | 509 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 65 | $0.00 |
| 87510 | 0% | 382 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 1,770 | $0.00 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 800 | $0.00 |
| 87147 | 0% | 390 | $0.00 | |
| 83690 | 0% | 281 | $0.00 | |
| 88141 | 0% | 142 | $0.00 | |
| 83014 | 0% | 150 | $0.00 | |
| 84153 | 0% | 194 | $0.00 | |
| 87088 | 0% | 4,202 | $0.00 | |
| 83615 | 0% | 71 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 2,138 | $0.00 |
| 86364 | 0% | 245 | $0.00 | |
| 86800 | 0% | 25 | $0.00 | |
| 86704 | 0% | 99 | $0.00 | |
| 86706 | 0% | 56 | $0.00 | |
| 82670 | 0% | 12 | $0.00 | |
| 97014 | 0% | 74 | $0.00 | |
| 96156 | 0% | 26 | $0.00 | |
| 97010 | 0% | 472 | $0.00 | |
| 83002 | 0% | 53 | $0.00 | |
| 87046 | 0% | 24 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 50 | $0.00 |
| 84270 | 0% | 12 | $0.00 | |
| 82784 | 0% | 87 | $0.00 | |
| 86317 | 0% | 15 | $0.00 | |
| 83520 | 0% | 29 | $0.00 | |
| 97016 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHYLEN, THERESA (CHIEF FINANCIAL OFFICER)
Parent organizationDIGNITY HEALTH MEDICAL FOUNDATION
| Provider | Location | Paid |
|---|---|---|
| Dignity Health Medical Foundation | Sacramento, CA | $14.76M |
| Dignity Health Medical Foundation | Santa Cruz, CA | $10.62M |
| Dignity Health Medical Foundation | Bakersfield, CA | $8.04M |
| Dignity Health Medical Foundation | Camarillo, CA | $4.19M |
| Dignity Health Medical Foundation | Redding, CA | $3.70M |
| Dignity Health Medical Foundation | Stockton, CA | $2.76M |
| Dignity Health Medical Foundation | Merced, CA | $2.22M |
| Dignity Health Medical Foundation | Belmont, CA | $2.11M |
| Dignity Health Medical Foundation | Northridge, CA | $1.93M |
| Dignity Health Medical Foundation | Rancho Cordova, CA | $1.28M |
| Dignity Health Medical Foundation | Grass Valley, CA | $536K |
| Dignity Health Medical Foundation | San Francisco, CA | $349K |
| Dignity Health Medical Foundation | Highland, CA | $257K |
| Dignity Health Medical Foundation | Rancho Cordova, CA | $32K |
| Dignity Health Medical Foundation | Fontana, CA | $3K |
| Dignity Health Medical Foundation | Elk Grove, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.